ESR2 and B-cell chronic lymphocytic leukemia: The results reveal that all gained and lost dREs display a significant enrichment of eight TFBSs (Fig. 6a), including those of NFKB1, estrogen receptor 2 (ESR1), and P53, all well-known for activating and maintaining B and CLL cells.